Drug
lisdexamfetamine dimesylate
Marketed as VYVANSE.
Generic name
lisdexamfetamine dimesylate
Brand names
VYVANSE
First FDA approval
2007-02-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA208510 | VYVANSE | 2017-01-28 | TAKEDA PHARMS USA |
| NDA021977 | VYVANSE | 2007-02-23 | TAKEDA PHARMS USA |
Manufacturers
TAKEDA PHARMS USA
Frequently asked questions
When was lisdexamfetamine dimesylate FDA approved?
Earliest FDA approval on record: 2007-02-23.
What brand names are sold as lisdexamfetamine dimesylate?
VYVANSE.
Sources
Appeal a lisdexamfetamine dimesylate denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com